Algomedix Competitors and Similar CompaniesClear all
CTI BioPharma's competitors and similar companies include Crinetics Pharmaceuticals.
 CTI BioPharma CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers that offer a benefit to patients and healthcare providers. |  Crinetics Pharmaceuticals Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company that develops and commercializes therapeutics for rare endocrine diseases and endocrine-related tumors. | |
Founding Date | Founding Date 1992 | Founding Date 2008 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Seattle, US HQ Köln, DE | Locations San Diego, US HQ |
Employees | Employees 2546% decrease | Employees 43751% increase |
Valuation ($) | Valuation ($) 1.2 b | Valuation ($) 5.1 b |
Financial | ||
Revenue (est.) | Revenue (est.) $53.9m (FY, 2022) | Revenue (est.) $7.7m (FY, 2025) |
Cost of goods | Cost of goods $3.5m (FY, 2022) | Cost of goods $1.1m (FY, 2025) |
Gross profit | Gross profit $50.4m (FY, 2022) | Gross profit $6.6m (FY, 2025) |
Net income | Net income ($93m) (FY, 2022) | Net income ($465.3m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 105m | Total funding raised $ 41.5m |
For sources of this data, please see the company profile
View Company Profiles
Crinetics Pharmaceuticals
HQ
San Diego, US
Employees
437
Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company that develops and commercializes therapeutics for rare endocrine diseases and endocrine-related tumors.
View company